Cancer trials Sustained overall survival benefit with avelumab maintenance in advanced urothelial carcinoma
Clinical Practice Lorlatinib: a new player in the evolving first-line treatment landscape for patients with ALK-...
Health Innovation Leuven-based tech company reports promising results with new imaging technology for low-grade ...
Covid-19 ASSOCIATIONS BETWEEN CLINICAL FACTORS AND RECENT ANTICANCER THERAPIES IN PATIENTS WITH CANCER ...
ELCC 2022 Savolitinib in the treatment of patients with non-small cell lung cancer and MET exon 14 skipp...
